SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-028014
Filing Date
2021-05-14
Accepted
2021-05-14 16:08:16
Documents
47
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q life-10q_20210331.htm 10-Q 1780416
2 EX-31.1 life-ex311_6.htm EX-31.1 9624
3 EX-31.2 life-ex312_10.htm EX-31.2 9125
4 EX-32.1 life-ex321_7.htm EX-32.1 5500
5 EX-32.2 life-ex322_8.htm EX-32.2 5452
  Complete submission text file 0001564590-21-028014.txt   5422490

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT life-20210331.xml EX-101.INS 1065100
7 XBRL TAXONOMY EXTENSION SCHEMA life-20210331.xsd EX-101.SCH 39170
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE life-20210331_cal.xml EX-101.CAL 41817
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE life-20210331_def.xml EX-101.DEF 136559
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE life-20210331_lab.xml EX-101.LAB 318864
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE life-20210331_pre.xml EX-101.PRE 234396
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37378 | Film No.: 21924615
SIC: 2836 Biological Products, (No Diagnostic Substances)